\
&
Contact us
\
&
Contact us
Starts in 2 weeks from now
LocationOnline
ProgrammesThis event aims to inform potential applicants about the funding opportunities of the Horizon Europe Cluster 4 - 'Digital, Industry and Space' Work Programme 2025.
Speakers from the European Commission will provide detailed insights into the call topics, evaluation and award processes. Attendees will have the opportunity to pose questions about new developments and learn how to draft successful proposals.
Draft agenda
13 May 2025
14 May 2025
More information on the event and the means to follow the event can be found on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
